In recent weeks there has been more and more talk of new generation vaccines for next autumn, when we will probably have products calibrated on Omicron and related sub-variants available. With the concrete possibility that inoculations and storage can be simpler thanks to spray vaccines, with several companies engaged in experiments in this regard.
The road is not short, experts admit. But the studies begin to grow. As well as spray vaccine candidates in development (there are 8 nasal vaccines in clinical development and 3 in phase 3 studies, according to the journal Scientific American online). A promise that follows a slower path, but that could be a little closer to the finish line.
L’immunologo
“It is the most difficult immunization, the most complex modality to develop. But the one that would work best “, he explains to theberaking latest news Salute Mario Clerici, professor of immunology at the University of Milan and scientific director of the Don Gnocchi Foundation. Where are we at? Among the works that evaluate this approach there is a recent one, published in ‘Science Translational Medicine’ and visible online, in which a team of scientists explains how an anti-Covid vaccine administered by mouth or nose can help raise the barrier against Sars-CoV-2 infection. The authors define it as a viable strategy, capable of reducing both disease and airborne transmission. The article reports the results of an animal test with an adenoviral vector vaccine candidate. There is a need for vaccines that also act as a barrier to transmission, especially with the advent of variants – and Omicron sub-variants, such as 4 and 5 – increasingly contagious.
The publications
The international media also devote focus to the topic, one of the most recent is the one that in the ‘New York Times’ hosts the intervention of a scientist, Akiko Iwasakileading a team at Yale University working on just that: a new approach to vaccination with systemic vaccines that train the entire body’s immune response, followed by boosters administered directly into the nasal cavity, to provide special protection in the part of the body. body most affected by Sars-CoV-2 infection.
“Ideally a nasal vaccine – explains the expert – could enter the mucus layer inside the nose and help the body make antibodies that capture the virus before it has a chance to attach itself to people’s cells. By capturing the virus right at the site of infection, the antibodies induced by nasal vaccines can give an edge in the fight ”to Sars-CoV-2“ by acting before it causes symptoms ”. These vaccines, Iwasaki continues, “can establish highly protective memory B cells and memory T cells.”
A study just made available on the ‘BioRxiv’ platform, signed by German scientists, sought to compare different approaches to vaccination, evaluating potential differences insystemic and mucosal immunity conferred by different vaccines and different vaccination regimens that mix various types of shield products. The various options were tested in hamsters and all regimens containing the live attenuated vaccine candidate sCPD9, which is administered intranasally, showed superior efficacy.
The robust immunity elicited – the study reads – was evident in a wide range of immune parameters, from rapid viral clearance to strong systemic and mucosal humoral responses and rapid recall of memory T cells from lung tissue. Our results show that the use of live attenuated vaccines may offer advantages over available Covid-19 vaccinesespecially if applied as a booster “after a primary cycle, is the conclusion of the experts.
“The key point – Clerici comments – is that the virus enters through the respiratory mucous membranes. With a nasal vaccine, the vaccine compound is brought in place and the presence of IgA antibodies is stimulated. Which are mucosal, cover the tissues of the upper respiratory tract and prevent the virus from coming into contact with them. Therefore the virus does not enter the organism. To give another example, a high concentration of vaginal IgA protects against HIV infection with heterosexual transmission “.
In collaboration with beraking latest news